Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

A DNAzyme‐Based Nanohybrid for Ultrasound and Enzyme Dual‐Controlled mRNA Regulation and Combined Tumor Treatment

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Versatile Catalytic Deoxyribozyme Vehicles for Multimodal Imaging-Guided Efficient Gene Regulation and Photothermal Therapy.

A Self‐Catabolic Multifunctional DNAzyme Nanosponge for Programmable Drug Delivery and Efficient Gene Silencing

An Endogenous Mirna-Initiated Hybridization Chain Reaction and Subsequent DNAzyme Activation for Cellular Theranostics

A Smart Metal-Polyphenol-DNAzyme nanoplatform for Gene-Chemodynamic Synergistic Tumor therapy

Self‐Adaptive Activation of DNAzyme Nanoassembly for Synergistically Combined Gene Therapy

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

A Double DNAzyme-loaded MnO2 Versatile Nanodevice for Precise Cancer Diagnosis and Self-Sufficient Synergistic Gene Therapy

Self-Assembly Of Copper-Dnazyme Nanohybrids For Dual-Catalytic Tumor Therapy

Engineering self-catabolic DNAzyme nanospheres for synergistic anticancer therapy

A Targeted DNAzyme-Nanocomposite Probe Equipped with Built-in Zn2+ Arsenal for Combined Treatment of Gene Regulation and Drug Delivery

A Multifunctional DNA Nanoassembly for Cancer Cell Detection and Combined Gene-Chemotherapy Therapy.

A smart mRNA-initiated DNAzyme nanogenerator for precise imaging and gene therapy in vivo

Advancing DNAzyme Technology in Tumor Treatment

Visualized and Cascade-Enhanced Gene Silencing by Smart DNAzyme-graphene Nanocomplex

A Hybrid Nanoassembly for Ultrasound-Inducible Cytosolic Sirna Delivery and Cancer Sono-Gene Therapy.

Triggered Amplification of Gene Theranostics with High Accuracy and Efficacy Using Metallo-Nanoassemblies

A DNA Nanocomplex Containing Cascade DNAzymes and Promoter‐Like Zn‐Mn‐Ferrite for Combined Gene/Chemo‐dynamic Therapy

A Proton‐Activatable DNA‐Based Nanosystem Enables Co‐Delivery of CRISPR/Cas9 and DNAzyme for Combined Gene Therapy

Metal organic framework coated MnO<sub>2</sub> nanosheets delivering doxorubicin and self -activated DNAzyme for chemo-gene combinatorial treatment of cancer